Estrogen-induced miR-196a elevation promotes tumor growth and metastasis via targeting SPRED1 in breast cancer-Reference-Cited by-同舟云学术

Estrogen-induced miR-196a elevation promotes tumor growth and metastasis via targeting SPRED1 in breast cancer

Published:2018-04-23 Issue:1 Volume:17 Page:
ISSN:1476-4598
Container-title:Molecular Cancer
language:en
Short-container-title:Mol Cancer

Author:

Jiang Cheng-Fei,Shi Zhu-Mei,Li Dong-Mei,Qian Ying-Chen,Ren Yi,Bai Xiao-Ming,Xie Yun-Xia,Wang Lin,Ge Xin,Liu Wei-Tao,Zhen Lin-Lin,Liu Ling-Zhi,Jiang Bing-Hua

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Foundation for the National Institutes of Health

Huai'an City 533 Excellence Project

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12943-018-0830-0.pdf

Reference58 articles.

1. Ban KA, Godellas CV. Epidemiology of breast cancer. Surg Oncol Clin N Am. 2014;23:409–22.

2. Bolt MJ, Stossi F, Callison AM, Mancini MG, Dandekar R, Mancini MA. Systems level-based RNAi screening by high content analysis identifies UBR5 as a regulator of estrogen receptor-alpha protein levels and activity. Oncogene. 2015;34:154–64.

3. Chan HJ, Li H, Liu Z, Yuan YC, Mortimer J, Chen S. SERPINA1 is a direct estrogen receptor target gene and a predictor of survival in breast cancer patients. Oncotarget. 2015;6:25815–27.

4. Thomas C, Gustafsson JA. The different roles of ER subtypes in cancer biology and therapy. Nat Rev Cancer. 2011;11:597–608.

5. Nilsson S, Gustafsson JA. Estrogen receptors: therapies targeted to receptor subtypes. Clin Pharmacol Ther. 2011;89:44–55.

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the impact of estrogen exposure on ovarian cancer: A comprehensive risk model and immune landscape analysis;Toxicology Mechanisms and Methods;2024-09-09

2. miR-196a in the carcinogenesis and other disorders with an especial focus on its biomarker capacity;Pathology - Research and Practice;2024-08

3. Identification of TAP1 as a T-cell related therapeutic target in gastric cancer by mediating oxalipliatin-related synergistic enhancement of immunotherapy;International Immunopharmacology;2024-05

4. Oestrogen promotes the progression of adenomyosis by inhibiting CITED2 through miR-145;Reproductive BioMedicine Online;2024-05

5. Prediction of CAF-related genes in immunotherapy and drug sensitivity in hepatocellular carcinoma: a multi-database analysis;Genes & Immunity;2024-01-17